

[ Tue, Mar 25th 2014
] - WOPRAI
[ Tue, Mar 25th 2014
] - WOPRAI
[ Tue, Mar 25th 2014
] - WOPRAI
[ Tue, Mar 25th 2014
] - WOPRAI

[ Mon, Mar 24th 2014
] - WOPRAI
[ Mon, Mar 24th 2014
] - WOPRAI

[ Fri, Mar 21st 2014
] - WOPRAI
[ Fri, Mar 21st 2014
] - WOPRAI
[ Fri, Mar 21st 2014
] - WOPRAI

[ Thu, Mar 20th 2014
] - WOPRAI
[ Thu, Mar 20th 2014
] - WOPRAI
[ Thu, Mar 20th 2014
] - WOPRAI
[ Thu, Mar 20th 2014
] - WOPRAI
[ Thu, Mar 20th 2014
] - WOPRAI

[ Wed, Mar 19th 2014
] - WOPRAI
[ Wed, Mar 19th 2014
] - WOPRAI
[ Wed, Mar 19th 2014
] - WOPRAI
[ Wed, Mar 19th 2014
] - WOPRAI

[ Tue, Mar 18th 2014
] - WOPRAI
[ Tue, Mar 18th 2014
] - WOPRAI
[ Tue, Mar 18th 2014
] - WOPRAI

[ Mon, Mar 17th 2014
] - WOPRAI
[ Mon, Mar 17th 2014
] - WOPRAI

[ Fri, Mar 14th 2014
] - WOPRAI
[ Fri, Mar 14th 2014
] - WOPRAI
Chris Schott Upgraded (TEVA) to Hold and Held Target at $49 on, Mar 14th, 2014
Chris Schott of JP Morgan, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold and Held Target at $49 on, Mar 14th, 2014.
Chris has made no other calls on TEVA in the last 4 months.
There are 3 other peers that have a rating on TEVA. Out of the 3 peers that are also analyzing TEVA, 1 agrees with Chris's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Randall Stanicky of "RBC Capital" Initiated at Hold and Held Target at $39 on, Monday, January 6th, 2014
These are the ratings of the 2 analyists that currently disagree with Chris
- Ami Fadia of "Leerink Swann" Upgraded from Hold to Buy on, Thursday, March 6th, 2014
- Liav Abraham of "Citigroup" Maintained at Strong Buy with Increased Target to $56 on, Monday, March 3rd, 2014